Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that sevelamer hydrochloride is non-inferior to
calcium acetate for the treatment of hyperphosphataemia in patients receiving peritoneal
dialysis.